Status:
COMPLETED
Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer
Lead Sponsor:
International Breast Cancer Research Foundation
Collaborating Sponsors:
Breast Cancer Research Foundation
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
This study will determine if hormone receptor positive premenopausal metastatic breast cancer patients who undergo removal of the ovaries in mid-luteal versus mid-follicular phase have a longer surviv...
Detailed Description
Rationale: Previous research suggests that women who have their ovaries removed as part of their treatment for breast cancer may live longer if the ovarian surgery is performed during the luteal phase...
Eligibility Criteria
Inclusion
- Estrogen receptor or progesterone receptor positive breast cancer
- Premenopausal with regular menstrual cycles
Exclusion
- Current oral contraceptives
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
249 Patients enrolled
Trial Details
Trial ID
NCT00293540
Start Date
February 1 2006
End Date
March 1 2015
Last Update
July 27 2016
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University
Columbus, Ohio, United States, 43210
2
Dhaka Medical College Hospital
Dhaka, Bangladesh
3
4th Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
4
Beijing Hospital
Beijing, China